vs
芝商所(CME)与国际香精香料(IFF)财务数据对比。点击上方公司名可切换其他公司
国际香精香料的季度营收约是芝商所的1.4倍($2.6B vs $1.9B),国际香精香料净利率更高(0.2% vs 0.1%,领先0.1%),芝商所同比增速更快(14.5% vs -6.6%),过去两年芝商所的营收复合增速更高(10.8% vs -5.5%)
芝商所是总部位于美国伊利诺伊州芝加哥的金融服务企业,为全球规模最大的金融衍生品交易所运营商,旗下拥有芝加哥商品交易所、芝加哥期货交易所、纽约商业交易所、纽约商品交易所等交易平台,覆盖农产品、货币、能源等品类交易,同时持有标普道琼斯指数27%的股权。
国际香精香料(IFF)是美国知名企业,业务覆盖风味、质感、香氛、营养、酶制剂、菌种、大豆蛋白、益生菌等多品类产品研发,产品行销全球。公司总部位于纽约,在44个国家设有创意、销售及生产基地,是标普500指数成分股企业。
CME vs IFF — 直观对比
营收规模更大
IFF
是对方的1.4倍
$1.9B
营收增速更快
CME
高出21.0%
-6.6%
净利率更高
IFF
高出0.1%
0.1%
两年增速更快
CME
近两年复合增速
-5.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.9B | $2.6B |
| 净利润 | $1.2M | $5.0M |
| 毛利率 | — | 34.4% |
| 营业利润率 | 0.1% | 3.7% |
| 净利率 | 0.1% | 0.2% |
| 营收同比 | 14.5% | -6.6% |
| 净利润同比 | 20.7% | 110.9% |
| 每股收益(稀释后) | — | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CME
IFF
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.6B | $2.6B | ||
| Q3 25 | $1.5B | $2.7B | ||
| Q2 25 | $1.7B | $2.8B | ||
| Q1 25 | $1.6B | $2.8B | ||
| Q4 24 | $1.5B | $2.8B | ||
| Q3 24 | $1.6B | $2.9B | ||
| Q2 24 | $1.5B | $2.9B |
净利润
CME
IFF
| Q1 26 | $1.2M | — | ||
| Q4 25 | $1.2B | $5.0M | ||
| Q3 25 | $908.0M | $40.0M | ||
| Q2 25 | $1.0B | $612.0M | ||
| Q1 25 | $956.2M | $-1.0B | ||
| Q4 24 | $874.6M | $-46.0M | ||
| Q3 24 | $912.8M | $59.0M | ||
| Q2 24 | $883.2M | $170.0M |
毛利率
CME
IFF
| Q1 26 | — | — | ||
| Q4 25 | — | 34.4% | ||
| Q3 25 | — | 36.5% | ||
| Q2 25 | — | 37.3% | ||
| Q1 25 | — | 36.4% | ||
| Q4 24 | — | 35.4% | ||
| Q3 24 | — | 36.0% | ||
| Q2 24 | — | 37.0% |
营业利润率
CME
IFF
| Q1 26 | 0.1% | — | ||
| Q4 25 | 61.8% | 3.7% | ||
| Q3 25 | 63.3% | 8.4% | ||
| Q2 25 | 66.7% | 7.2% | ||
| Q1 25 | 67.5% | -31.8% | ||
| Q4 24 | 62.1% | 4.6% | ||
| Q3 24 | 64.6% | 8.5% | ||
| Q2 24 | 65.3% | 6.6% |
净利率
CME
IFF
| Q1 26 | 0.1% | — | ||
| Q4 25 | 71.7% | 0.2% | ||
| Q3 25 | 59.1% | 1.5% | ||
| Q2 25 | 60.6% | 22.1% | ||
| Q1 25 | 58.2% | -35.8% | ||
| Q4 24 | 57.3% | -1.7% | ||
| Q3 24 | 57.6% | 2.0% | ||
| Q2 24 | 57.6% | 5.9% |
每股收益(稀释后)
CME
IFF
| Q1 26 | — | — | ||
| Q4 25 | $3.24 | $0.03 | ||
| Q3 25 | $2.49 | $0.16 | ||
| Q2 25 | $2.81 | $2.38 | ||
| Q1 25 | $2.62 | $-3.98 | ||
| Q4 24 | $2.40 | $-0.17 | ||
| Q3 24 | $2.50 | $0.23 | ||
| Q2 24 | $2.42 | $0.66 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $2.4B | $590.0M |
| 总债务越低越好 | $3.4B | $5.6B |
| 股东权益账面价值 | — | $14.2B |
| 总资产 | $202.0B | $25.5B |
| 负债/权益比越低杠杆越低 | — | 0.40× |
8季度趋势,按日历期对齐
现金及短期投资
CME
IFF
| Q1 26 | $2.4B | — | ||
| Q4 25 | $4.5B | $590.0M | ||
| Q3 25 | $2.6B | $621.0M | ||
| Q2 25 | $2.1B | $816.0M | ||
| Q1 25 | $1.5B | $613.0M | ||
| Q4 24 | $3.0B | $469.0M | ||
| Q3 24 | $2.4B | $567.0M | ||
| Q2 24 | $1.9B | $671.0M |
总债务
CME
IFF
| Q1 26 | $3.4B | — | ||
| Q4 25 | — | $5.6B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $8.9B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益
CME
IFF
| Q1 26 | — | — | ||
| Q4 25 | $28.7B | $14.2B | ||
| Q3 25 | $28.2B | $14.2B | ||
| Q2 25 | $27.7B | $14.4B | ||
| Q1 25 | $27.0B | $13.2B | ||
| Q4 24 | $26.5B | $13.9B | ||
| Q3 24 | $28.2B | $14.8B | ||
| Q2 24 | $27.6B | $14.3B |
总资产
CME
IFF
| Q1 26 | $202.0B | — | ||
| Q4 25 | $198.4B | $25.5B | ||
| Q3 25 | $187.1B | $25.8B | ||
| Q2 25 | $179.9B | $26.1B | ||
| Q1 25 | $157.8B | $28.3B | ||
| Q4 24 | $137.4B | $28.7B | ||
| Q3 24 | $137.8B | $29.9B | ||
| Q2 24 | $123.4B | $29.5B |
负债/权益比
CME
IFF
| Q1 26 | — | — | ||
| Q4 25 | — | 0.40× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.64× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $318.0M |
| 自由现金流经营现金流 - 资本支出 | — | $130.0M |
| 自由现金流率自由现金流/营收 | — | 5.0% |
| 资本支出强度资本支出/营收 | — | 7.3% |
| 现金转化率经营现金流/净利润 | — | 63.60× |
| 过去12个月自由现金流最近4个季度 | — | $256.0M |
8季度趋势,按日历期对齐
经营现金流
CME
IFF
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $318.0M | ||
| Q3 25 | $968.1M | $164.0M | ||
| Q2 25 | $1.1B | $241.0M | ||
| Q1 25 | $1.1B | $127.0M | ||
| Q4 24 | $1.0B | $368.0M | ||
| Q3 24 | $1.0B | $366.0M | ||
| Q2 24 | $776.9M | $237.0M |
自由现金流
CME
IFF
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $130.0M | ||
| Q3 25 | $949.7M | $32.0M | ||
| Q2 25 | $1.0B | $146.0M | ||
| Q1 25 | $1.1B | $-52.0M | ||
| Q4 24 | $991.7M | $208.0M | ||
| Q3 24 | $973.2M | $263.0M | ||
| Q2 24 | $758.7M | $155.0M |
自由现金流率
CME
IFF
| Q1 26 | — | — | ||
| Q4 25 | 66.8% | 5.0% | ||
| Q3 25 | 61.8% | 1.2% | ||
| Q2 25 | 61.5% | 5.3% | ||
| Q1 25 | 67.1% | -1.8% | ||
| Q4 24 | 65.0% | 7.5% | ||
| Q3 24 | 61.4% | 9.0% | ||
| Q2 24 | 49.5% | 5.4% |
资本支出强度
CME
IFF
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 7.3% | ||
| Q3 25 | 1.2% | 4.9% | ||
| Q2 25 | 1.1% | 3.4% | ||
| Q1 25 | 0.9% | 6.3% | ||
| Q4 24 | 1.7% | 5.8% | ||
| Q3 24 | 1.9% | 3.5% | ||
| Q2 24 | 1.2% | 2.8% |
现金转化率
CME
IFF
| Q1 26 | — | — | ||
| Q4 25 | 0.96× | 63.60× | ||
| Q3 25 | 1.07× | 4.10× | ||
| Q2 25 | 1.03× | 0.39× | ||
| Q1 25 | 1.17× | — | ||
| Q4 24 | 1.16× | — | ||
| Q3 24 | 1.10× | 6.20× | ||
| Q2 24 | 0.88× | 1.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CME
暂无分部数据
IFF
| Food Ingredients | $802.0M | 31% |
| Scent | $610.0M | 24% |
| Other | $589.0M | 23% |
| Taste | $588.0M | 23% |